Follow

Submissions from 2015

PDF

Applying cognitive load theory to medical education: construct and measurement challenges, John Young and J. L. Sewell

Link

Prevalence of behavioral health disorders and associated chronic disease burden in a commercially insured health system: findings of a case-control study, J. Q. Young, A. H. Kline-Simon, D. J. Mordecai, and C. Weisner

Link

Temperament and prodromal symptoms prior to first manic/hypomanic episodes: results from a pilot study, E. Zeschel, T. Bingmann, A. Bechdolf, S. Kruger-Oezguerdal, C. U. Correll, K. Leopold, A. Pfennig, M. Bauer, and G. Juckel

Link

A functional polymorphism in the interleukin-1beta and severity of nicotine dependence in male schizophrenia: a case-control study, X. Y. Zhang, D. C. Chen, Y. L. Tan, S. P. Tan, X. Luo, L. Zuo, W. Rao, Q. Yu, C. Kou, M. Allen, Christoph Correll, J. Wu, and J. C. Soares

Link

Frequency and Correlates of Distant Visual Impairment in Patients with Schizophrenia, Bipolar Disorder, and Major Depressive Disorder, W. Zheng, L. R. Tang, Christoph Correll, G. S. Ungvari, H. F. Chiu, Y. Q. Xiang, and Y. T. Xiang

Glutamatergic agents for schizophrenia: current evidence and perspectives, M. Zink and Christoph Correll

Submissions from 2014

Link

Should full adherence be a necessary goal in schizophrenia? Full versus non-full adherence to antipsychotic treatment, F. J. Acosta, Y. Ramallo-Farina, and S. G. Siris

PDF

Substance use in clinical high risk for psychosis: a review of the literature, J. Addington, N. Case, M. M. Saleem, A. M. Auther, B. A. Cornblatt, and K. S. Cadenhead

Link

Prevalence of Nurses' Smoking Habits in Psychiatric and General Hospitals in China, F. R. An, D. S. F. Yu, K. Y. C. Lai, Y. K. Qi, J. Y. Zeng, P. P. Wu, Z. J. Hou, C. U. Correll, R. Newhouse, H. F. K. Chiu, and +5 additional authors

Link

Second-Generation Antipsychotic Use in Children and Adolescents: A Six-Month Prospective Cohort Study in Drug-Naive Patients, C. Arango, M. Giraldez, J. Merchan-Naranjo, C. Moreno, P. de Andres, C. Cuerda, E. de la Serna, C. U. Correll, D. Fraguas, M. Parellada, and +4 additional authors

PDF

Latent Factor Modeling of Four Schizotypy Dimensions with Theory of Mind and Empathy, J. S. Bedwell, M. T. Compton, F. G. Jentsch, A. E. Deptula, S. M. Goulding, and E. B. Tone

PDF

The Subjective Experience of Youths at Clinically High Risk of Psychosis: A Qualitative Study, S. Ben-David, M. L. Birnbaum, M. E. Eilenberg, J. E. DeVylder, K. E. Gill, J. Schienle, N. Azimov, E. P. Lukens, L. Davidson, and C. M. Corcoran

Link

The Role of Atypical Antipsychotics for Treatment of Tourette's Syndrome: An Overview, C. L. Budman

PDF

Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications, K. E. Burdick, M. Russo, S. Frangou, K. Mahon, R. J. Braga, M. Shanahan, and A. K. Malhotra

PDF

Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study, L. Citrome, P. J. Weiden, J. P. McEvoy, C. U. Correll, J. Cucchiaro, J. Hsu, and A. Loebel

The Relative Importance of Family History, Gender, Mode of Onset, and Age at Onset in Predicting Clinical Features of First-Episode Psychotic Disorders, M. T. Compton, C. Berez, and E. F. Walker

Link

This issue: The Social Determinants of Mental Health, M. T. Compton and R. Shim

PDF

Neural activation during response inhibition in adult attention-deficit/hyperactivity disorder: Preliminary findings on the effects of medication and symptom severity, E. Congdon, L. L. Altshuler, J. A. Mumford, K. H. Karlsgodt, F. W. Sabb, J. Ventura, E. D. London, T. D. Cannon, R. M. Bilder, R. A. Poldrack, and +1 additional author

Link

Can an early weight management program (WMP) prevent olanzapine (OLZ)-induced disturbances in body weight, blood glucose and lipid metabolism? Twenty-four- and 48-week results from a 6-month randomized trial, J. Cordes, J. Thunker, G. Regenbrecht, J. Zielasek, C. U. Correll, C. Schmidt-Kraepelin, C. Lange-Asschenfeldt, W. Gaebel, A. Klimke, H. Hauner, and +2 additional authors

Recognition of patients who would benefit from LAI antipsychotic treatment: how to assess adherence, C. Correll

Mechanism of action of antipsychotic medications, C. U. Correll

The role of the extended health care team in successful LAI therapy: education to overcome barriers, C. U. Correll

Link

Efficacy of Pharmacologic and Psychotherapeutic Interventions in Psychiatry To Talk or to Prescribe: Is That the Question?, C. U. Correll and M. Carbon

Link

Schizophrenia: Mechanism of Action of Current and Novel Treatments, C. U. Correll and J. M. Kane

Link

Prioritization of Research Addressing Antipsychotics for Adolescents and Young Adults With Bipolar Disorder, M. J. Crowley, D. C. McCrory, R. Chatterjee, J. M. Gierisch, E. R. Myers, K. M. Schmit, R. R. Coeytaux, C. U. Correll, A. S. Kendrick, and G. D. Sanders

Patterns of variation influencing antipsychotic treatment outcomes in South African first-episode schizophrenia patients, B. I. Drogemoller, D. J. Niehaus, B. Chiliza, L. van der Merwe, L. Asmal, A. K. Malhotra, G. E. Wright, R. Emsley, and L. Warnich

PDF

The SORL1 gene and convergent neural risk for Alzheimer's disease across the human lifespan, D. Felsky, P. Szeszko, L. Yu, W. G. Honer, P. L. De Jager, J. A. Schneider, A. K. Malhotra, T. Lencz, T. Ikuta, A. N. Voineskos, and +7 additional authors

Link

How Do Clinicians Actually Use the Diagnostic and Statistical Manual of Mental Disorders in Clinical Practice and Why We Need to Know More, M. B. First, V. Bhat, D. Adler, L. Dixon, B. Goldman, S. Koh, B. Levine, D. Oslin, and S. G. Siris

PDF

Effects of aripiprazole once-monthly on domains of personal and social performance: Results from 2 multicenter, randomized, double-blind studies, W. W. Fleischhacker, R. A. Baker, A. Eramo, R. Sanchez, L. F. Tsai, T. Peters-Strickland, P. P. Perry, R. D. McQuade, B. R. Johnson, W. H. Carson, and J. M. Kane

Link

Completed and Attempted Suicides Among 18,154 Subjects With Schizophrenia Included in a Large Simple Trial, W. W. Fleischhacker, J. M. Kane, J. Geier, O. Karayal, S. Kolluri, S. M. Eng, R. F. Reynolds, and B. L. Strom

Link

Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study, W. W. Fleischhacker, R. Sanchez, T. Peters-Strickland, B. R. Johnson, R. A. Baker, A. Eramo, R. D. McQuade, W. H. Carson, D. Walling, J. M. Kane, and +2 additional authors

Link

Cross-cultural invariance of the factor structure of the Schizotypal Personality Questionnaire across Spanish and American college students, E. Fonseca-Pedrero, M. T. Compton, E. B. Tone, J. Ortuno-Sierra, M. Paino, A. Fumero, and S. Lemos-Giraldez

Link

Review of Care of Children Exposed to the Traumatic Effects of Disaster, by Jon A. Shaw, Zelde Espinel, and James M. Shultz, V. Fornari

Link

National Trends in Second-Generation Antipsychotic Augmentation for Nonpsychotic Depression, T. Gerhard, A. Akincigil, C. U. Correll, N. J. Foglio, S. Crystal, and M. Olfson

Link

A D1 Receptor Antagonist, Ecopipam, for Treatment of Tics in Tourette Syndrome, D. L. Gilbert, C. L. Budman, H. S. Singer, R. Kurlan, and R. E. Chipkin

PDF

Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles, J. I. Goldstein, L. F. Jarskog, C. Hilliard, A. Alfirevic, H. L. Huang, M. Lek, A. L. Holden, D. L. Kelly, A. K. Malhotra, P. F. Sullivan, and +21 additional authors

Early Intervention for Adolescents at High Risk for the Development of Bipolar Disorder: Pilot Study of Interpersonal and Social Rhythm Therapy (IPSRT), T. R. Goldstein, R. Fersch-Podrat, D. A. Axelson, A. Gilbert, S. A. Hlastala, B. Birmaher, and E. Frank

Link

Frequency of Involuntary Admissions and Its Associations With Demographic and Clinical Characteristics in China, L. Gou, J. S. Zhou, Y. T. Xiang, X. M. Zhu, C. U. Correll, G. S. Ungvari, H. F. K. Chiu, K. Y. C. Lai, and X. P. Wang

Link

Suicidality and hospitalization as cause and outcome of pediatric psychiatric emergency room visits, E. Grudnikoff, E. C. Soto, A. Frederickson, M. L. Birnbaum, E. Saito, R. Dicker, J. M. Kane, and C. U. Correll

Link

Characteristics and disposition of youth referred from schools for emergency psychiatric evaluation, E. Grudnikoff, T. Taneli, and C. U. Correll

Link

The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches, S. Gupta, J. D. Cahill, M. Ranganathan, and C. U. Correll

PDF

Predicting risky choices from brain activity patterns, S. M. Helfinstein, T. Schonberg, E. Congdon, K. H. Karlsgodt, J. A. Mumford, F. W. Sabb, T. D. Cannon, E. D. London, R. M. Bilder, and R. A. Poldrack

PDF

Sudden unexpected death in schizophrenia: Autopsy findings in psychiatric inpatients, P. Ifteni, C. U. Correll, V. Burtea, J. M. Kane, and P. Manu

Link

Rapid clozapine titration in treatment-refractory bipolar disorder, P. Ifteni, C. U. Correll, J. Nielsen, V. Burtea, J. M. Kane, and P. Manu

PDF

Schizophrenia relapse after stopping olanzapine treatment during pregnancy: a case report, P. Ifteni, M. A. Moga, V. Burtea, and C. U. Correll

Link

Effectiveness and safety of rapid clozapine titration in schizophrenia, P. Ifteni, J. Nielsen, V. Burtea, C. U. Correll, J. M. Kane, and P. Manu

PDF

Altered white matter microstructure is associated with social cognition and psychotic symptoms in 22q11.2 microdeletion syndrome, M. Jalbrzikowski, J. E. Villalon-Reina, K. H. Karlsgodt, D. Senturk, C. Chow, P. M. Thompson, and C. E. Bearden

Clinical and cost implications of treating schizophrenia: safety, efficacy, relapse prevention, and patient outcomes, J. M. Kane, C. U. Correll, P. D. Harvey, and M. Olfson

Link

Attitudinal barriers to prescribing LAI antipsychotics in the outpatient setting: communicating with patients, families, and caregivers, John Kane

Financial incentives improve adherence to maintenance antipsychotic treatment, John Kane

Link

Technology-based interventions in health care, John Kane

Link

Aripiprazole Once-Monthly in the Acute Treatment of Schizophrenia: Findings From a 12-Week, Randomized, Double-Blind, Placebo-Controlled Study, John Kane, T. Peters-Strickland, R. A. Baker, P. Hertel, A. Eramo, N. Jin, P. P. Perry, M. Gara, R. D. McQuade, R. Sanchez, and +1 additional author

PDF

Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysis, John Kane, C. Zhao, B. R. Johnson, R. A. Baker, A. Eramo, R. D. McQuade, A. R. Duca, R. Sanchez, and T. Peters-Strickland

PDF

Altered relationships between age and functional brain activation in adolescents at clinical high risk for psychosis, K. H. Karlsgodt, T. G. M. van Erp, C. E. Bearden, and T. D. Cannon

Link

Brief Pulse and Ultrabrief Pulse Right Unilateral Electroconvulsive Therapy (ECT) for Major Depression: Efficacy, Effectiveness, and Cognitive Effects, C. H. Kellner, S. M. McClintock, W. V. McCall, G. Petrides, R. G. Knapp, R. D. Weiner, R. C. Young, R. M. Greenberg, M. V. Rudorfer, S. H. Lisanby, and +2 additional authors

PDF

The Relation Between Diabetes Self-Efficacy and Psychological Distress Among Older Adults: Do Racial and Ethnic Differences Exist?, G. Kim, Ruth Shim, K. L. Ford, and T. A. Baker

Link

A Call to Restructure Psychiatry General and Subspecialty Training, P. Kirwin; M. Conroy; C. Lyketsos; Blaine Greenwald; B. Forester; C. Devries; II Ahmed; I. Wiechers; K. Zdanys; D. Steffens; and C. F., 3rd Reynolds

Link

Effects of the child-perpetrator relationship on mental health outcomes of child abuse: It's (not) all relative, L. J. Kiser, C. S. Stover, C. P. Navalta, J. Dorado, J. M. Vogel, J. K. Abdul-Adil, S. Kim, R. C. Lee, R. Vivrette, and E. C. Briggs

Link

The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males, E. Koiliari, P. Roussos, E. Pasparakis, T. Lencz, Anil Malhotra, L. J. Siever, S. G. Giakoumaki, and P. Bitsios

PDF

Optimal treatment of Alzheimer's disease psychosis: challenges and solutions, Jeremy Koppel and Blaine Greenwald

PDF

Does a GLP-1 receptor agonist change glucose tolerance in patients treated with antipsychotic medications? Design of a randomised, double-blinded, placebo-controlled clinical trial, J. R. Larsen, L. Vedtofte, J. J. Holst, P. Oturai, A. Kjaer, Christoph Correll, T. Vilsboll, and A. Fink-Jensen

Link

Symptomatic and functional remission of subjects at clinical high risk for psychosis: A 2-year naturalistic observational study, T. Y. Lee, S. N. Kim, Christoph Correll, M. S. Byun, E. Kim, J. H. Jang, D. H. Kang, J. Y. Yun, and J. S. Kwon

Link

Characteristics, symptomatology and naturalistic treatment in individuals at-risk for bipolar disorders: Baseline results in the first 180 help-seeking individuals assessed at the dresden high-risk project, K. Leopold, S. Ratzer, Christoph Correll, M. Rottmann-Wolf, S. Pfeiffer, P. Ritter, M. Bauer, and A. Pfennig

Link

Erratum to: Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: A randomized, double-blind, active parallel-controlled, multicenter clinical trial (vol 157, pg 112, 2014), H. F. Li, J. F. Luo, C. Y. Wang, S. P. Xie, X. F. Xu, X. P. Wang, W. J. Yu, N. F. Gu, and J. M. Kane

Link

Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: A randomized, double-blind, active parallel-controlled, multicenter clinical trial, H. F. Li, J. F. Luo, C. Y. Wang, S. P. Xie, X. F. Xu, X. P. Wang, W. J. Yu, N. F. Gu, and John Kane

PDF

Genes and Schizophrenia: From a Festschrift Seminar Honoring William T. Carpenter Jr, MD, Anil Malhotra

PDF

Markers of inflammation in schizophrenia: association vs. causation, P. Manu, C. U. Correll, M. Wampers, A. J. Mitchell, M. Probst, D. Vancampfort, and M. De Hert

PDF

The content of attenuated psychotic symptoms in those at clinical high risk for psychosis, C. Marshall, E. Denny, K. S. Cadenhead, T. D. Cannon, Barbara Cornblatt, T. H. McGlashan, D. O. Perkins, L. J. Seidman, M. T. Tsuang, J. Addington, and +2 additional authors

Link

Could the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) be used in depressed schizophrenia patients?, X. R. Ma, C. L. Hou, Y. Zang, F. J. Jia, Y. Q. Lin, Y. Li, H. F. Chiu, G. S. Ungvari, Christoph Correll, Y. T. Xiang, and +5 additional authors

Link

Predicting and preventing bipolar disorder: the need to fundamentally advance the strategic approach, R. S. McIntyre and Christoph Correll

PDF

The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study, E. C. Meyer, Ricardo Carrion, Barbara Cornblatt, J. Addington, K. S. Cadenhead, T. D. Cannon, T. H. McGlashan, D. O. Perkins, M. T. Tsuang, L. J. Seidman, and +3 additional authors

PDF

Disrupted working memory circuitry and psychotic symptoms in 22q11.2 deletion syndrome, C. A. Montojo, A. Ibrahim, K. H. Karlsgodt, C. Chow, A. E. Hilton, R. K. Jonas, T. K. Vesagas, and C. E. Bearden

Link

A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression, J. C. Nelson, P. Baumann, K. Delucchi, R. T. Joffe, and C. Katona

Link

Comment on 'effectiveness and safety of rapid clozapine titration in schizophrenia' Reply, J. Nielsen, P. Ifteni, P. Manu, J. Kane, and C. Correll

PDF

Comparative Effectiveness of Risperidone Long-Acting Injectable vs First-Generation Antipsychotic Long-Acting Injectables in Schizophrenia: Results From a Nationwide, Retrospective Inception Cohort Study, J. Nielsen, S. O. Jensen, R. B. Friis, J. B. Valentin, and Christoph Correll

Link

Risk of Diabetes in Children and Adolescents Exposed to Antipsychotics: A Nationwide 12-Year Case-Control Study, R. E. Nielsen, M. F. Laursen, D. L. Vernal, C. Bisgaard, H. Jakobsen, H. C. Steinhausen, and Christoph Correll

Link

The relationship between temperament and character and subclinical psychotic-like experiences in healthy adults, G. C. Nitzburg, Anil Malhotra, and P. DeRosse

Link

National Trends in the Mental Health Care of Children, Adolescents, and Adults by Office-Based Physicians, M. Olfson, C. Blanco, S. Wang, G. Laje, and Christoph Correll

Link

No Causal Association Between Electroconvulsive Therapy and Death A Summary of a Report From the Danish Health and Medicines Authority Covering 99,728 Treatments, S. D. Ostergaard, T. G. Bolwig, and G. Petrides

Risk factors for conversion from unipolar psychotic depression to bipolar disorder, S. D. Ostergaard, S. Straszek, G. Petrides, S. Skadhede, S. O. W. Jensen, P. Munk-Jorgensen, and J. Nielsen

PDF

Quetiapine versus aripiprazole in children and adolescents with psychosis - protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial, A. K. Pagsberg, P. Jeppesen, D. G. Klauber, K. G. Jensen, D. Ruda, M. Stentebjerg-Olesen, P. Jantzen, S. Rasmussen, Christoph Correll, B. Fagerlund, and +19 additional authors

PDF

Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials, A. K. Pagsberg, S. Tarp, D. Glintborg, A. D. Stenstrom, A. Fink-Jensen, Christoph Correll, and R. Christensen

PDF

SENTIA: a systematic online monitoring registry for children and adolescents treated with antipsychotics, I. Palanca-Maresca, B. Ruiz-Antoran, G. Centeno-Soto, S. Jimenez-Fernandez, L. Garcia-Murillo, A. Siles, S. Villagra, H. Blasco-Fontecilla, L. Iruela-Cuadrado, Christoph Correll, and +2 additional authors

PDF

Genetic Association Signal Near NTN4 in Tourette Syndrome, P. Paschou, D. M. Yu, G. Gerber, P. Evans, F. Tsetsos, L. K. Davis, Cathy Budman, C. A. Mathews, J. M. Scharf, and +29 additional authors

PDF

Towards a Psychosis Risk Blood Diagnostic for Persons Experiencing High-Risk Symptoms: Preliminary Results From the NAPLS Project, D. O. Perkins, C. D. Jeffries, J. Addington, C. E. Bearden, K. S. Cadenhead, T. D. Cannon, Barbara Cornblatt, D. H. Mathalon, S. W. Woods, R. Heinssen, and +4 additional authors

Link

Psychotherapeutic interventions in individuals at risk of developing bipolar disorder: a systematic review, A. Pfennig, C. U. Correll, C. Marx, M. Rottmann-Wolf, T. D. Meyer, M. Bauer, and K. Leopold

PDF

Early specific cognitive-behavioural psychotherapy in subjects at high risk for bipolar disorders: study protocol for a randomised controlled trial, A. Pfennig, K. Leopold, A. Bechdolf, C. U. Correll, M. Holtmann, M. Lambert, C. Marx, T. D. Meyer, G. Juckel, M. Bauer, and +5 additional authors

Link

Adherence to Guidelines for Glucose Assessment in Starting Second-Generation Antipsychotics, M. A. Raebel, R. Penfold, A. W. McMahon, M. Reichman, S. Shetterly, G. Goodrich, S. Andrade, C. U. Correll, and T. Gerhard

PDF

Biological insights from 108 schizophrenia-associated genetic loci, S. Ripke, B. M. Neale, A. Corvin, J. T. R. Walters, K. H. Farh, T. Lencz, A. K. Malhotra, Consortium Psychiat Genomics, Conso Psychosis Endophenotypes Int, Consor Wellcome Trust Case-Control, and +292 additional authors

PDF

Child and Adolescent Psychiatrists' Attitudes and Practices Prescribing Second Generation Antipsychotics, A. M. Rodday, S. K. Parsons, C. U. Correll, A. S. Robb, B. T. Zima, T. S. Saunders, and L. K. Leslie

PDF

Affective temperaments and neurocognitive functioning in bipolar disorder, M. Russo, K. Mahon, M. Shanahan, E. Ramjas, C. Solon, R. Braga, and K. E. Burdick

Link

Initial evidence for sex-specific effects of early emotional abuse on affective processing in bipolar disorder, M. Russo, R. Proujansky, A. Gilbert, R. Braga, and K. E. Burdick

PDF

Perceived discrimination in those at clinical high risk for psychosis, M. M. Saleem, J. Stowkowy, K. S. Cadenhead, T. D. Cannon, B. Cornblatt, T. H. McGlashan, D. O. Perkins, L. J. Seidman, M. T. Tsuang, S. W. Woods, and +2 additional authors

Link

Diabetes risk potentially underestimated in youth and children receiving antipsychotics, K. Samaras, C. U. Correll, A. J. Mitchell, and M. De Hert

PDF

Default mode network connectivity and reciprocal social behavior in 22q11.2 deletion syndrome, M. J. Schreiner, K. H. Karlsgodt, L. Q. Uddin, C. Chow, E. Congdon, M. Jalbrzikowski, and C. E. Bearden

Link

A 6-week randomized, double-blind, placebo-controlled, comparator referenced trial of vabicaserin in acute schizophrenia, J. H. Q. Shen, Y. G. Zhao, S. Rosenzweig-Lipson, D. Popp, J. B. W. Williams, E. Giller, M. J. Detke, and J. Kane

The Social Determinants of Mental Health: An Overview and Call to Action, R. Shim, C. Koplan, F. J. P. Langheim, M. W. Manseau, R. A. Powers, and M. Compton

Link

Datapoints: psychiatrists' perceptions of insurance-related medication access barriers, R. Shim, C. Lally, R. Farley, C. Ingoglia, and B. G. Druss

Link

Medical Care Services in Community Mental Health Centers: a National Survey of Psychiatrists, R. Shim, C. Lally, R. Farley, C. Ingoglia, and B. G. Druss

Link

A meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia, B. Stubbs, M. De Hert, A. A. Sepehry, C. U. Correll, A. J. Mitchell, A. Soundy, J. Detraux, and D. Vancampfort